Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic Science Track

Persistence of the ABC transporter-mediated efflux at the physically disrupted blood-brain barrier: a 11C-erlotinib PET imaging study in rats

Sebastien Goutal, Sylvain Auvity, Matthieu Gerstenmayer, Fabien Caille, Irene Buvat, Benoit Larrat and Nicolas Tournier
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 64;
Sebastien Goutal
2CEA/SHFJ/IMIV Orsay France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylvain Auvity
2CEA/SHFJ/IMIV Orsay France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthieu Gerstenmayer
1CEA/NeuroSpin Gif sur Yvette France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabien Caille
2CEA/SHFJ/IMIV Orsay France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irene Buvat
2CEA/SHFJ/IMIV Orsay France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benoit Larrat
1CEA/NeuroSpin Gif sur Yvette France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas Tournier
2CEA/SHFJ/IMIV Orsay France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 59 no. supplement 1 64

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 23, 2018.

Copyright & Usage 
© 2018

Author Information

  1. Sebastien Goutal2,
  2. Sylvain Auvity2,
  3. Matthieu Gerstenmayer1,
  4. Fabien Caille2,
  5. Irene Buvat2,
  6. Benoit Larrat1 and
  7. Nicolas Tournier2
  1. 1CEA/NeuroSpin Gif sur Yvette France
  2. 2CEA/SHFJ/IMIV Orsay France

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2018 to January 2023

AbstractFullPdf
May 20181800
Jun 20183800
Jul 20181500
Aug 20181000
Sep 2018200
Oct 20181900
Nov 20181700
Dec 20181300
Jan 20191400
Feb 2019700
Mar 2019200
Apr 2019500
May 2019900
Jun 2019200
Jul 20191500
Aug 2019400
Sep 2019500
Oct 2019700
Nov 2019500
Dec 20191400
Jan 2020800
Feb 2020600
Mar 20202100
Apr 20201300
May 2020700
Jun 2020900
Jul 2020300
Aug 20202200
Sep 20203000
Oct 20201300
Nov 20202200
Dec 20201800
Jan 2021600
Feb 2021700
Mar 20211200
Apr 20211300
May 2021800
Jun 2021800
Jul 20212000
Aug 20213800
Sep 20211500
Oct 20211900
Nov 20218100
Dec 20214500
Jan 20228400
Feb 20222500
Mar 20223800
Apr 20222200
May 20223400
Jun 2022400
Jul 2022500
Aug 2022700
Sep 2022400
Oct 2022300
Nov 2022700
Dec 2022200
Jan 20231300
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 59, Issue supplement 1
May 1, 2018
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Persistence of the ABC transporter-mediated efflux at the physically disrupted blood-brain barrier: a 11C-erlotinib PET imaging study in rats
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Persistence of the ABC transporter-mediated efflux at the physically disrupted blood-brain barrier: a 11C-erlotinib PET imaging study in rats
Sebastien Goutal, Sylvain Auvity, Matthieu Gerstenmayer, Fabien Caille, Irene Buvat, Benoit Larrat, Nicolas Tournier
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 64;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Persistence of the ABC transporter-mediated efflux at the physically disrupted blood-brain barrier: a 11C-erlotinib PET imaging study in rats
Sebastien Goutal, Sylvain Auvity, Matthieu Gerstenmayer, Fabien Caille, Irene Buvat, Benoit Larrat, Nicolas Tournier
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 64;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Basic Science Track

  • Imaging adult glioma with 68Ga-citrate PET/MR
  • Evaluation of L-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of Cancer
  • Pretargeted radioimmunotherapy with 225Ac-proteus-DOTA hapten.
Show more Oncology, Basic Science Track

Radiolabeled Small Molecules and New Applications - Oncology

  • Brain tumor PET imaging in a transgenic medulloblastoma mouse model using a novel 18F- labeled tryptophan tracer
  • Photo-catalyzed 18F-fluorination of leucine and leucine analogues for system L imaging
Show more Radiolabeled Small Molecules and New Applications - Oncology

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire